Researchers have developed a new method to measure levels of the anti-malarial drug hydroxychloroquine (HCQ) in patients with lupus.
A disadvantage of hydroxychloroquine is its side effects which can be avoided, however, if the dosage is adjusted for each patient, said the study researchers from Uppsala University in Sweden.
